Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus

Biol Psychiatry. 2001 Mar 15;49(6):528-39. doi: 10.1016/s0006-3223(00)00968-9.

Abstract

Background: Abnormalities in the glutamatergic system, glutamate/dopamine/gamma-aminobutyric acid interactions, and cortical development are implicated in schizophrenia. Moreover, patients with schizophrenia show symptom exacerbation in response to N-methyl-D-aspartate (NMDA) antagonist drugs. Using an animal model of schizophrenia, we compared the impact of neonatal and adult hippocampal lesions on behavioral responses to MK-801, a noncompetitive NMDA antagonist.

Methods: Neonatal rats were lesioned on postnatal day 7. Their motor activity in response to MK-801 was tested at a juvenile age, in adolescence, and in adulthood. We also measured binding of [(3)H]MK-801 and the expression of NR1 messenger RNA (mRNA) in the medial prefrontal cortex and nucleus accumbens. Adult rats received similar lesions and were tested 4 and 8 weeks after the lesion.

Results: As juveniles, neonatally lesioned rats did not differ from control rats in responsiveness to MK-801, whereas in adolescence and adulthood they showed more pronounced hyperactivity than control rats. The adult lesion did not alter behaviors elicited by MK-801. Neonatally lesioned rats showed no apparent changes in [(3)H]MK-801 binding or expression of the NR1 mRNA.

Conclusions: These results suggest that an early lesion of the ventral hippocampus affects development of neural systems involved in MK-801 action without changes at the NMDA receptor level, and they show that the behavioral changes manifest first in early adulthood.

MeSH terms

  • Age Factors
  • Animals
  • Animals, Newborn
  • Behavior, Animal / drug effects*
  • Binding, Competitive / physiology
  • Disease Models, Animal*
  • Dizocilpine Maleate / adverse effects*
  • Dizocilpine Maleate / pharmacokinetics
  • Dopamine / metabolism
  • Excitatory Amino Acid Antagonists / adverse effects*
  • Excitatory Amino Acid Antagonists / pharmacokinetics
  • Female
  • Hippocampus / drug effects*
  • Hyperkinesis / chemically induced*
  • In Situ Hybridization
  • Nucleus Accumbens / metabolism
  • Prefrontal Cortex / metabolism
  • RNA, Messenger / drug effects
  • Random Allocation
  • Rats
  • Receptors, N-Methyl-D-Aspartate / metabolism

Substances

  • Excitatory Amino Acid Antagonists
  • NR1 NMDA receptor
  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate
  • Dizocilpine Maleate
  • Dopamine